AXIM Biotechnologies, Inc.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.3M | $-292.3K | $-1.9M | $328.5K | $-3.7M | $-2.8M | $-899.1K | $-2.0M |
| Depreciation & Amortization | $108.1K | $108.0K | $106.8K | $106.8K | $106.8K | $106.8K | $106.8K | $106.7K |
| Depreciation | $9.4K | $9.4K | $8.3K | $8.1K | $8.0K | $8.1K | $8.2K | $8.1K |
| Amortization | $98.6K | $98.6K | $98.6K | $98.6K | $98.6K | $98.6K | $98.6K | $98.6K |
| Stock-Based Compensation | $9.6K | $9.6K | $34.1K | $38.4K | $21.4K | $103.8K | $219.2K | $517.2K |
| Net Cash from Operating Activities | $-261.5K | $-252.5K | $19.6K | $-264.5K | $-643.6K | $-142.0K | $-315.5K | $-321.2K |
| Investing Activities | ||||||||
| Capital Expenditures | — | $2.8K | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $0 | $-2.8K | $0 | $0 | $0 | $0 | $0 | $-2.7K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $170.9K | $195.6K | $113.7K | $190.2K | $687.6K | $148.2K | $199.0K | $422.5K |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | — | $-255.3K | — | — | — | — | — | — |